发明名称 Enantiomerically pure beta -d-dioxolane nucleosides
摘要 A method and composition for the treatment of humans infected with HIV that includes the administration of an HIV treatment amount of an enantiomerically pure beta -D-dioxolanyl purine nucleoside of the formula: <IMAGE> wherein R is OH, Cl, NH2, or H, or a pharmaceutically acceptable salt or derivative of the compound, optionally in a pharmaceutically acceptable carrier or diluent.
申请公布号 US5767122(A) 申请公布日期 1998.06.16
申请号 US19950469465 申请日期 1995.06.06
申请人 EMORY UNIVERSITY;THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 发明人 CHU, CHUNG K.;SCHINAZI, RAYMOND F.
分类号 C07D473/18;A61K31/505;A61K31/506;A61K31/513;A61K31/52;A61K31/522;A61K31/53;A61K31/675;A61K31/7076;A61K38/21;A61P31/12;A61P31/18;A61P37/04;C07D327/04;C07D405/04;C07D411/04;C07D473/00;C07D473/16;C07D473/30;C07D473/34;C07D473/40;C07D497/08;C07F9/6561;(IPC1-7):C07D473/00 主分类号 C07D473/18
代理机构 代理人
主权项
地址